Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

Little is known of the changes in human immunodeficiency virus type 1 (HIV-1)-specific effector cytotoxic T lymphocytes (CTL) after potent antiretroviral therapy. Using HLA/peptide tetrameric complexes, we show that after starting treatment, there are early rapid fluctuations in the HIV-1-specific C...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., Markowitz, M., Ho, D. D., McMichael, A. J., Nixon, D. F.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 1999
Sujets:
Pathogenesis and Immunity
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC103892/
https://ncbi.nlm.nih.gov/pubmed/9847391
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires